Leo Pharma's team in Boston: "We send 5-10 possibilities back to Denmark each month"

Leo Science & Tech Hub in the biotech city Boston has already initiated a number of collaborations of new technologies in the field of dematology. This summer, it will send its first two validated projects back the the headquarters in Denmark, says Michael Sierra, Head of the US office.

Michael Sierra, VP, Leo Science & Tech Hub. Photo: Leo Pharma/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles